Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,147 | 315 | 99.1% |
| Education | $44.31 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,048 | 66 | $0 (2024) |
| Abbott Laboratories | $667.29 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $527.22 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $437.80 | 31 | $0 (2024) |
| PFIZER INC. | $385.01 | 27 | $0 (2024) |
| ABBVIE INC. | $349.68 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238.36 | 17 | $0 (2024) |
| Exact Sciences Corporation | $201.12 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $179.91 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $173.38 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,471 | 85 | Novo Nordisk Inc ($284.17) |
| 2023 | $1,322 | 70 | AstraZeneca Pharmaceuticals LP ($283.33) |
| 2022 | $928.64 | 59 | Novo Nordisk Inc ($352.06) |
| 2021 | $510.70 | 38 | AbbVie Inc. ($146.61) |
| 2018 | $44.83 | 4 | AstraZeneca Pharmaceuticals LP ($12.26) |
| 2017 | $913.22 | 62 | PFIZER INC. ($203.12) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.98 | General |
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Biological | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.34 | General |
| 10/16/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: VACCINES | ||||||
| 10/02/2024 | Biogen, Inc. | SPINRAZA (Biological), SKYCLARYS | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neurology | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Obesity | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Oncology | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 732 | 1,121 | $280,681 | $106,871 |
| 2022 | 11 | 663 | 1,073 | $255,575 | $94,278 |
| 2021 | 12 | 637 | 1,103 | $253,037 | $94,995 |
| 2020 | 12 | 847 | 1,405 | $180,231 | $89,117 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 589 | $165,509 | $57,262 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 152 | 152 | $43,624 | $21,385 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 95 | $18,905 | $5,600 | 29.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 75 | 76 | $11,123 | $5,443 | 48.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 19 | $11,647 | $4,586 | 39.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $6,348 | $3,380 | 53.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 80 | $5,352 | $2,630 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,030 | $2,597 | 32.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $6,370 | $2,495 | 39.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 20 | $2,340 | $914.20 | 39.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $798.00 | $394.44 | 49.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $533.00 | $126.90 | 23.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 17 | $102.00 | $57.97 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 561 | $158,388 | $53,992 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 80 | 80 | $22,465 | $11,363 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 124 | $24,729 | $8,033 | 32.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 23 | $14,089 | $5,483 | 38.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 81 | 81 | $11,331 | $5,480 | 48.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 32 | 46 | $9,200 | $3,123 | 33.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $6,813 | $2,736 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 81 | 81 | $5,318 | $2,632 | 49.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 18 | 20 | $2,340 | $941.11 | 40.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $722.00 | $390.54 | 54.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 23 | 30 | $180.00 | $103.08 | 57.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 218 | 602 | $169,174 | $61,228 | 36.2% |
About Dr. Steven Meskin, MD
Dr. Steven Meskin, MD is a Family Medicine healthcare provider based in Glassboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851335285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Meskin, MD has received a total of $5,191 in payments from pharmaceutical and medical device companies, with $1,471 received in 2024. These payments were reported across 318 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,147).
As a Medicare-enrolled provider, Meskin has provided services to 2,879 Medicare beneficiaries, totaling 4,702 services with total Medicare billing of $385,261. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Glassboro, NJ
- Active Since 06/15/2006
- Last Updated 01/20/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851335285
Products in Payments
- FREESTYLE LIBRE 3 (Device) $511.44
- Rybelsus (Drug) $422.19
- Ozempic (Drug) $310.82
- JARDIANCE (Drug) $234.51
- Cologuard Collection Kit (Device) $201.12
- BREZTRI (Drug) $198.52
- FARXIGA (Drug) $180.73
- INVOKANA (Drug) $158.46
- TRELEGY ELLIPTA (Drug) $158.11
- UBRELVY (Drug) $157.60
- AREXVY (Drug) $133.53
- SHINGRIX (Biological) $129.87
- QULIPTA (Drug) $104.23
- FREESTYLE LIBRE 2 (Device) $95.08
- VRAYLAR (Drug) $87.85
- AIRSUPRA (Drug) $80.53
- ELIQUIS (Drug) $77.84
- Victoza (Drug) $77.77
- Veozah (Drug) $77.32
- LYRICA (Drug) $76.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Glassboro
Dr. Bac Nguyen, Md, MD
Family Medicine — Payments: $18,248
Jon Heist, Do, DO
Family Medicine — Payments: $7,427
Ms. Mavola Tench, Md, MD
Family Medicine — Payments: $4,622
Dr. Joseph Szgalsky, Md, Faafp, MD, FAAFP
Family Medicine — Payments: $4,197
Durr-E-Shahwaar Sayed, Do, DO
Family Medicine — Payments: $2,963
Anna Alberici, D.o, D.O
Family Medicine — Payments: $1,514